Accordingly, we reasoned that, by activating anti-Tregs specific for PD-L1 and ARG1 derived epitopes through peptide vaccination, it may be an effective strategy to reinstate immune homeostasis in patients with MPN by immunomodulation of the tumor microenvironment and promotion of the tumor-specific T cell responses. This evidence concerns the gene CD274 and neoplasm.